Page 81 - EJMO-9-2
P. 81
Eurasian Journal of
Medicine and Oncology Gut microbiota and hyperuricemia: Mechanisms and therapeutic strategies
Purinergic Signal. 2023;19:315-327. doi: 10.1016/j.cell.2023.06.010
doi: 10.1007/s11302-022-09891-1 50. Marco ML, Sanders ME, Gänzle M, et al. The International
40. Shao T, Shao L, Li H, Xie Z, He Z, Wen C. Combined Scientific Association for Probiotics and Prebiotics
signature of the fecal microbiome and metabolome in (ISAPP) consensus statement on fermented foods. Nat Rev
patients with gout. Front Microbiol. 2017;8:268. Gastroenterol Hepatol. 2021;18(3):196-208.
doi: 10.3389/fmicb.2017.00268 doi: 10.1038/s41575-020-00390-5
41. Guo Z, Zhang J, Wang Z, et al. Intestinal microbiota 51. Dimidi E, Christodoulides S, Scott SM, Whelan K.
distinguish gout patients from healthy humans. Sci Mechanisms of action of probiotics and the gastrointestinal
Rep. 2016;6:20602. microbiota on gut motility and constipation. Adv Nutr.
2017;8(3):484-494.
doi: 10.1038/srep20602
doi: 10.3945/an.116.014407
42. Chu Y, Sun S, Huang Y, et al. Metagenomic analysis revealed
the potential role of gut microbiome in gout. NPJ Biofilms 52. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA.
Microbiomes. 2021;7(1):66. Probiotics and prebiotics in intestinal health and disease:
from biology to the clinic [published correction appears in
doi: 10.1038/s41522-021-00235-2 Nat Rev Gastroenterol Hepatol. 2019;16(10):642.
43. He L, Tang W, Huang L, et al. Rational design of a genome- doi: 10.1038/s41575-019-0199-6]. Nat Rev Gastroenterol
based insulated system in Escherichia coli facilitates Hepatol. 2019;16(10):605-616.
heterologous uricase expression for hyperuricemia
treatment. Bioeng Transl Med. 2022;8(2):e10449. doi: 10.1038/s41575-019-0173-3
doi: 10.1002/btm2.10449 53. Wang H, Mei L, Deng Y, et al. Lactobacillus brevis DM9218
ameliorates fructose-induced hyperuricemia through
44. Liu X, Lv Q, Ren H, et al. The altered gut microbiota of high-
purine-induced hyperuricemia rats and its correlation with inosine degradation and manipulation of intestinal
dysbiosis. Nutrition. 2019;62:63-73.
hyperuricemia. PeerJ. 2020;8:e8664.
doi: 10.1016/j.nut.2018.11.018
doi: 10.7717/peerj.8664
54. Rodríguez JM, Garranzo M, Segura J, et al. A randomized
45. Sapankaew T, Thadanipon K, Ruenroengbun N, et al.
Efficacy and safety of urate-lowering agents in asymptomatic pilot trial assessing the reduction of gout episodes
hyperuricemia: Systematic review and network meta- in hyperuricemic patients by oral administration of
analysis of randomized controlled trials. BMC Nephrol. Ligilactobacillus salivarius CECT 30632, a strain with the
2022;23(1):223. ability to degrade purines. Front Microbiol. 2023;14:1111652.
doi: 10.1186/s12882-022-02850-3 doi: 10.3389/fmicb.2023.1111652
46. Wang J, Chen Y, Zhong H, et al. The gut microbiota as a 55. Wei Z, Cui Y, Tian L, et al. Probiotic Lactiplantibacillus
target to control hyperuricemia pathogenesis: Potential plantarum N-1 could prevent ethylene glycol-induced
mechanisms and therapeutic strategies. Crit Rev Food Sci kidney stones by regulating gut microbiota and enhancing
Nutr. 2022;62(14):3979-3989. intestinal barrier function. FASEB J. 2021;35(11):e21937.
doi: 10.1080/10408398.2021.1874287 doi: 10.1096/fj.202100887RR
47. Dong L, Dong F, Guo P, et al. Gut microbiota as a new 56. Li Y, Zhu J, Lin G, et al. Probiotic effects of Lacticaseibacillus
target for hyperuricemia: A perspective from natural plant rhamnosus 1155 and Limosilactobacillus fermentum 2644 on
products. Phytomedicine. 2025;138:156402. hyperuricemic rats. Front Nutr. 2022;9:993951.
doi: 10.1016/j.phymed.2025.156402 doi: 10.3389/fnut.2022.993951
48. Ananthakrishnan AN, Luo C, Yajnik V, et al. Gut 57. Ni C, Li X, Wang L, et al. Lactic acid bacteria strains relieve
microbiome function predicts response to anti-integrin hyperuricaemia by suppressing xanthine oxidase activity via
biologic therapy in inflammatory bowel diseases. Cell Host a short-chain fatty acid-dependent mechanism. Food Funct.
Microbe. 2017;21(5):603-610.e3. 2021;12(15):7054-7067.
doi: 10.1016/j.chom.2017.04.010 doi: 10.1039/d1fo00198a
49. Liu Y, Jarman JB, Low YS, et al. A widely distributed gene 58. Zou Y, Ro KS, Jiang C, et al. The anti-hyperuricemic and gut
cluster compensates for uricase loss in hominids [published microbiota regulatory effects of a novel purine assimilatory
correction appears in Cell. 2023;186(20):4472-4473. strain, Lactiplantibacillus plantarum X7022 [published
correction appears in Eur J Nutr. 2024;63(5):1997.
doi: 10.1016/j.cell.2023.08.036]. Cell. 2023;186(16):3400-
3413.e20. doi: 10.1007/s00394-024-03382-2]. Eur J Nutr.
Volume 9 Issue 2 (2025) 73 doi: 10.36922/ejmo.8579

